ERBB2 and triple-negative breast carcinoma: This study found that although BMFS in HER2-positive and triple-negative breast cancers was significantly shorter than the luminal type in univariate analysis, further multivariate analysis found that only triple-negative subtypes were independent prognostic factors affecting BMFS.